Ashvattha Therapeutics

Redwood City, CA · Founded 2015 · Privately Held (backing)

Developer of hydroxyl dendrimer therapeutics designed to meet the unmet medical needs in oncology, ophthalmology and inflammatory diseases. Ashvattha Therapeutics is based in Redwood City, CA and was founded in 2015. It was valued at $310 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $217 million across 4 recorded rounds; the latest was a $60.2 million later-stage round in Apr 2021.

PMV mark · valuation
$310.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$217.2M
Last round
Later Stage VC
Apr 2021

Who backs Ashvattha Therapeutics?

37 investors
InvestorType
Evolution VC PartnersVenture capital
Tribe CapitalOther
TEDCOVenture capital
Sand Hill AngelsVenture capital
Social CapitalVenture capital
Modi VenturesVenture capital
The Pay It Forward CompanyVenture capital
Transform Investments—
Plum Alley VenturesVenture capital
EcoR1 CapitalHedge fund
+ 27 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ashvattha Therapeutics investors

37 investors are on record for Ashvattha Therapeutics, including Evolution VC Partners, Tribe Capital, TEDCO and Sand Hill Angels. By type, the record holds 9 venture capital firms, 1 family office and 1 hedge fund. The later-stage round in Apr 2021 drew 107 investors.

Free account
More of Ashvattha Therapeutics with a free account
  • ·The complete investor list: 37 names
  • ·Watch Ashvattha Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 37 firms already write checks for companies like Ashvattha Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View